Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Table of Contents
1 Market Overview of Small Molecule Targeted Cancer Therapy
1.1 Small Molecule Targeted Cancer Therapy Market Overview
1.1.1 Small Molecule Targeted Cancer Therapy Product Scope
1.1.2 Small Molecule Targeted Cancer Therapy Market Status and Outlook
1.2 Global Small Molecule Targeted Cancer Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Small Molecule Targeted Cancer Therapy Market Size by Region (2018-2029)
1.4 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Region (2018-2023)
1.5 Global Small Molecule Targeted Cancer Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.2 Europe Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.4 Latin America Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
2 Small Molecule Targeted Cancer Therapy Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Small Molecules
2.1.3 Small Molecule Drug Conjugates
2.2 Global Small Molecule Targeted Cancer Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
3 Small Molecule Targeted Cancer Therapy Market Overview by Application
3.1 Introduction
3.1.1 Lymphoma
3.1.2 Melanoma
3.1.3 Multiple Myeloma
3.1.4 Breast Cancer
3.1.5 Prostate Cancer
3.1.6 Others
3.2 Global Small Molecule Targeted Cancer Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
4 Small Molecule Targeted Cancer Therapy Competition Analysis by Players
4.1 Global Small Molecule Targeted Cancer Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2022)
4.3 Date of Key Players Enter into Small Molecule Targeted Cancer Therapy Market
4.4 Global Top Players Small Molecule Targeted Cancer Therapy Headquarters and Area Served
4.5 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Small Molecule Targeted Cancer Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.1.4 Roche Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Gilead Sciences
5.2.1 Gilead Sciences Profile
5.2.2 Gilead Sciences Main Business
5.2.3 Gilead Sciences Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.2.4 Gilead Sciences Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Gilead Sciences Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.3.4 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.4.4 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 Bayer AG
5.5.1 Bayer AG Profile
5.5.2 Bayer AG Main Business
5.5.3 Bayer AG Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.5.4 Bayer AG Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer AG Recent Developments
5.6 GSK
5.6.1 GSK Profile
5.6.2 GSK Main Business
5.6.3 GSK Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.6.4 GSK Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 GSK Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.7.4 AstraZeneca Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.8.4 Johnson & Johnson Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
5.9 Teva
5.9.1 Teva Profile
5.9.2 Teva Main Business
5.9.3 Teva Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.9.4 Teva Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Recent Developments
5.10 Pfizer
5.10.1 Pfizer Profile
5.10.2 Pfizer Main Business
5.10.3 Pfizer Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.10.4 Pfizer Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Pfizer Recent Developments
5.11 Allergan
5.11.1 Allergan Profile
5.11.2 Allergan Main Business
5.11.3 Allergan Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.11.4 Allergan Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Allergan Recent Developments
5.12 Merck
5.12.1 Merck Profile
5.12.2 Merck Main Business
5.12.3 Merck Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.12.4 Merck Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Merck Recent Developments
5.13 Novartis
5.13.1 Novartis Profile
5.13.2 Novartis Main Business
5.13.3 Novartis Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.13.4 Novartis Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Novartis Recent Developments
5.14 Sanofi
5.14.1 Sanofi Profile
5.14.2 Sanofi Main Business
5.14.3 Sanofi Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.14.4 Sanofi Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Sanofi Recent Developments
5.15 Amgen
5.15.1 Amgen Profile
5.15.2 Amgen Main Business
5.15.3 Amgen Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.15.4 Amgen Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 Amgen Recent Developments
5.16 AbbVie
5.16.1 AbbVie Profile
5.16.2 AbbVie Main Business
5.16.3 AbbVie Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.16.4 AbbVie Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.16.5 AbbVie Recent Developments
5.17 Eli Lilly
5.17.1 Eli Lilly Profile
5.17.2 Eli Lilly Main Business
5.17.3 Eli Lilly Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.17.4 Eli Lilly Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.17.5 Eli Lilly Recent Developments
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Small Molecule Targeted Cancer Therapy Market Dynamics
11.1 Small Molecule Targeted Cancer Therapy Industry Trends
11.2 Small Molecule Targeted Cancer Therapy Market Drivers
11.3 Small Molecule Targeted Cancer Therapy Market Challenges
11.4 Small Molecule Targeted Cancer Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
Table 1. Global Market Small Molecule Targeted Cancer Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Small Molecule Targeted Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Small Molecule Targeted Cancer Therapy Market Size Share by Region (2018-2023)
Table 4. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2018-2023)
Table 9. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2024-2029)
Table 11. North America Small Molecule Targeted Cancer Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Small Molecule Targeted Cancer Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Small Molecule Targeted Cancer Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Small Molecule Targeted Cancer Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Small Molecule Targeted Cancer Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Small Molecule Targeted Cancer Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2024-2029)
Table 26. North America Small Molecule Targeted Cancer Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Small Molecule Targeted Cancer Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Small Molecule Targeted Cancer Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Small Molecule Targeted Cancer Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Small Molecule Targeted Cancer Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Small Molecule Targeted Cancer Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Small Molecule Targeted Cancer Therapy Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2022)
Table 39. Date of Key Players Enter into Small Molecule Targeted Cancer Therapy Market
Table 40. Global Small Molecule Targeted Cancer Therapy Key Players Headquarters and Area Served
Table 41. Small Molecule Targeted Cancer Therapy Product Solution and Service
Table 42. Global Small Molecule Targeted Cancer Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Roche Basic Information List
Table 45. Roche Description and Business Overview
Table 46. Roche Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Roche (2018-2023)
Table 48. Roche Recent Developments
Table 49. Gilead Sciences Basic Information List
Table 50. Gilead Sciences Description and Business Overview
Table 51. Gilead Sciences Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Gilead Sciences (2018-2023)
Table 53. Gilead Sciences Recent Developments
Table 54. Boehringer Ingelheim Basic Information List
Table 55. Boehringer Ingelheim Description and Business Overview
Table 56. Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Boehringer Ingelheim (2018-2023)
Table 58. Boehringer Ingelheim Recent Developments
Table 59. Abbott Laboratories Basic Information List
Table 60. Abbott Laboratories Description and Business Overview
Table 61. Abbott Laboratories Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Abbott Laboratories (2018-2023)
Table 63. Abbott Laboratories Recent Developments
Table 64. Bayer AG Basic Information List
Table 65. Bayer AG Description and Business Overview
Table 66. Bayer AG Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Bayer AG (2018-2023)
Table 68. Bayer AG Recent Developments
Table 69. GSK Basic Information List
Table 70. GSK Description and Business Overview
Table 71. GSK Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of GSK (2018-2023)
Table 73. GSK Recent Developments
Table 74. AstraZeneca Basic Information List
Table 75. AstraZeneca Description and Business Overview
Table 76. AstraZeneca Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of AstraZeneca (2018-2023)
Table 78. AstraZeneca Recent Developments
Table 79. Johnson & Johnson Basic Information List
Table 80. Johnson & Johnson Description and Business Overview
Table 81. Johnson & Johnson Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Johnson & Johnson (2018-2023)
Table 83. Johnson & Johnson Recent Developments
Table 84. Teva Basic Information List
Table 85. Teva Description and Business Overview
Table 86. Teva Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Teva (2018-2023)
Table 88. Teva Recent Developments
Table 89. Pfizer Basic Information List
Table 90. Pfizer Description and Business Overview
Table 91. Pfizer Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Pfizer (2018-2023)
Table 93. Pfizer Recent Developments
Table 94. Allergan Basic Information List
Table 95. Allergan Description and Business Overview
Table 96. Allergan Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Allergan (2018-2023)
Table 98. Allergan Recent Developments
Table 99. Merck Basic Information List
Table 100. Merck Description and Business Overview
Table 101. Merck Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Merck (2018-2023)
Table 103. Merck Recent Developments
Table 104. Novartis Basic Information List
Table 105. Novartis Description and Business Overview
Table 106. Novartis Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Novartis (2018-2023)
Table 108. Novartis Recent Developments
Table 109. Sanofi Basic Information List
Table 110. Sanofi Description and Business Overview
Table 111. Sanofi Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 112. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Sanofi (2018-2023)
Table 113. Sanofi Recent Developments
Table 114. Amgen Basic Information List
Table 115. Amgen Description and Business Overview
Table 116. Amgen Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 117. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Amgen (2018-2023)
Table 118. Amgen Recent Developments
Table 119. AbbVie Basic Information List
Table 120. AbbVie Description and Business Overview
Table 121. AbbVie Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 122. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of AbbVie (2018-2023)
Table 123. AbbVie Recent Developments
Table 124. Eli Lilly Basic Information List
Table 125. Eli Lilly Description and Business Overview
Table 126. Eli Lilly Small Molecule Targeted Cancer Therapy Products, Services and Solutions
Table 127. Revenue (US$ Million) in Small Molecule Targeted Cancer Therapy Business of Eli Lilly (2018-2023)
Table 128. Eli Lilly Recent Developments
Table 129. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 130. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 131. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 132. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 133. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 134. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 135. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 136. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Region (2018-2023)
Table 137. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Region (2024-2029)
Table 138. Latin America Small Molecule Targeted Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 139. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 140. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 141. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 142. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 143. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 144. Small Molecule Targeted Cancer Therapy Market Trends
Table 145. Small Molecule Targeted Cancer Therapy Market Drivers
Table 146. Small Molecule Targeted Cancer Therapy Market Challenges
Table 147. Small Molecule Targeted Cancer Therapy Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Targeted Cancer Therapy Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Small Molecule Targeted Cancer Therapy Market Share by Regions: 2022 VS 2029
Figure 4. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Small Molecule Targeted Cancer Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Small Molecule Targeted Cancer Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Small Molecule Targeted Cancer Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Monoclonal Antibodies
Figure 11. Global Monoclonal Antibodies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Small Molecules
Figure 13. Global Small Molecules Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Small Molecule Drug Conjugates
Figure 15. Global Small Molecule Drug Conjugates Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global Small Molecule Targeted Cancer Therapy Market Size Share by Type: 2022 & 2029
Figure 17. North America Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2018-2029)
Figure 18. Europe Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2018-2029)
Figure 20. Latin America Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2018-2029)
Figure 22. Lymphoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Melanoma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Multiple Myeloma Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Breast Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Prostate Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Global Small Molecule Targeted Cancer Therapy Market Size Share by Application: 2022 & 2029
Figure 29. North America Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2018-2029)
Figure 30. Europe Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2018-2029)
Figure 31. Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2018-2029)
Figure 32. Latin America Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2018-2029)
Figure 33. Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2018-2029)
Figure 34. Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 35. Global Top 5 and Top 10 Players Small Molecule Targeted Cancer Therapy Market Share in 2022
Figure 36. North America Small Molecule Targeted Cancer Therapy Market Share by Country (2018-2029)
Figure 37. U.S. Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 38. Canada Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 39. Germany Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 40. France Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 41. U.K. Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 42. Italy Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 43. Russia Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 44. Nordic Countries Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 45. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Region (2018-2029)
Figure 46. China Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 47. Japan Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 48. South Korea Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 49. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 50. India Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 51. Australia Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 52. Latin America Small Molecule Targeted Cancer Therapy Market Share by Country (2018-2029)
Figure 53. Mexico Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 54. Brazil Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 55. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Country (2018-2029)
Figure 56. Turkey Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 58. UAE Small Molecule Targeted Cancer Therapy Market Size (2018-2029) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs